0,741  0,004  Ulceration
0,726  0,010  GST A substrate
0,687  0,007  Cardiovascular analeptic
0,684  0,008  5 Hydroxytryptamine release stimulant
0,677  0,007  Eye irritation, high
0,672  0,004  Anesthetic general
0,613  0,009  5 Hydroxytryptamine release inhibitor
0,609  0,007  Cardiodepressant
0,595  0,019  Cholesterol antagonist
0,584  0,025  Teratogen
0,577  0,024  Embryotoxic
0,555  0,010  Skin irritative effect
0,562  0,017  Antipruritic, allergic
0,566  0,021  Respiratory analeptic
0,554  0,011  FMO1 substrate
0,543  0,027  Aldehyde oxidase inhibitor
0,533  0,023  Vasodilator, peripheral
0,528  0,023  CYP2C19 substrate
0,498  0,015  Antipyretic
0,499  0,023  Sensitization
0,487  0,013  Antihypertriglyceridemic
0,493  0,023  Analeptic
0,467  0,004  Tyrosine 3 hydroxylase inhibitor
0,491  0,029  Antiallergic
0,506  0,045  TNF expression inhibitor
0,484  0,025  Spasmolytic
0,462  0,006  Alpha-N-acetylglucosaminidase inhibitor
0,462  0,007  Antiparkinsonian, rigidity relieving
0,474  0,033  GABA C receptor rho-3 antagonist
0,473  0,039  Histamine release inhibitor
0,464  0,031  Antihypercholesterolemic
0,494  0,062  Caspase 9 stimulant
0,457  0,028  Cardioprotectant
0,464  0,035  Antithrombotic
0,452  0,023  Vasodilator, coronary
0,468  0,042  Immunosuppressant
0,450  0,028  Lipoprotein disorders treatment
0,435  0,014  Antiulcerative
0,429  0,010  Anesthetic
0,432  0,015  Calcium channel activator
0,417  0,005  Antiparkinsonian, tremor relieving
0,413  0,009  Antipruritic, non-allergic
0,423  0,023  Antiglaucomic
0,429  0,031  Apoptosis antagonist
0,408  0,013  5 Hydroxytryptamine uptake stimulant
0,487  0,093  Antiinflammatory
0,395  0,009  Pneumotoxic
0,452  0,071  Antiarthritic
0,403  0,023  Vasodilator
0,391  0,015  Non-steroidal antiinflammatory agent
0,411  0,037  Antiischemic
0,409  0,037  ICAM1 expression inhibitor
0,409  0,037  Antihypertensive
0,399  0,027  Platelet antagonist
0,396  0,028  Hypoglycemic
0,429  0,062  Calcium channel L-type activator
0,380  0,015  GST M1-1 substrate
0,422  0,059  Transcription factor NF kappa B inhibitor
0,390  0,027  Hypolipemic
0,377  0,014  Platelet adhesion inhibitor
0,384  0,023  FMO3 substrate
0,396  0,037  CTGF expression inhibitor
0,378  0,026  Psychostimulant
0,381  0,030  Antihypoxic
0,355  0,005  Neurotrophic factor
0,385  0,035  NOS2 expression inhibitor
0,352  0,004  Photosensitizer
0,382  0,034  Carcinogenic
0,373  0,025  Antineoplastic (endocrine cancer)
0,388  0,042  Radioprotector
0,373  0,027  Vascular (periferal) disease treatment
0,376  0,033  Mutagenic
0,404  0,061  CYP2C9 substrate
0,365  0,026  Flavin-containing monooxygenase substrate
0,351  0,012  Acaricide
0,372  0,038  UGT2B4 substrate
0,396  0,063  CYP3A4 substrate
0,336  0,008  Antihyperlipoproteinemic
0,410  0,085  Antidiabetic
0,410  0,085  Cyclophilin D inhibitor
0,357  0,034  Antidiabetic symptomatic
0,324  0,003  GST T1-1 substrate
0,365  0,047  Lipoxygenase inhibitor
0,361  0,044  UGT1A9 substrate
0,358  0,042  Chemoprotective
0,322  0,006  Excitatory amino acid transporter EAAC1 inhibitor
0,419  0,105  Apoptosis agonist
0,353  0,039  Radiosensitizer
0,352  0,038  Free radical scavenger
0,358  0,044  Antioxidant
0,322  0,009  UDP-glucose 4-epimerase inhibitor
0,329  0,017  Gastrin inhibitor
0,326  0,016  Hair growth stimulant
0,328  0,020  Antiseptic
0,333  0,025  Muscle relaxant
0,314  0,008  Aldehyde oxidase substrate
0,329  0,024  P-glycoprotein inhibitor
0,309  0,005  Cyclooxygenase 3 inhibitor
0,313  0,012  Phospholipase A2 inhibitor
0,320  0,018  Skeletal muscle relaxant
0,305  0,006  Carbonic anhydrase VI inhibitor
0,318  0,021  VCAM1 expression inhibitor
0,321  0,024  Antianginal
0,306  0,009  Carcinogenic, group 2B
0,331  0,035  Interleukin agonist
0,340  0,044  DNA damaging
0,321  0,026  Myocardial ischemia treatment
0,351  0,057  CYP2D6 substrate
0,306  0,012  Acute respiratory distress syndrome (ARDS) treatment
0,302  0,010  Carcinogenic, group 1
0,297  0,006  Carbonic anhydrase XIII inhibitor
0,326  0,038  Chemopreventive
0,299  0,012  Aldehyde dehydrogenase inhibitor
0,302  0,015  Antidote
0,322  0,039  UGT1A6 substrate
0,317  0,036  Cyclic AMP phosphodiesterase inhibitor
0,356  0,075  Stroke treatment
0,325  0,045  Proliferative diseases treatment
0,321  0,044  Transcription factor STAT3 inhibitor
0,293  0,017  Insulin sensitizer
0,301  0,026  UGT2B7 substrate
0,320  0,045  Transcription factor STAT inhibitor
0,291  0,017  GST P1-1 substrate
0,293  0,020  Neurotrophic factor enhancer
0,290  0,022  Carcinogenic, group 3
0,306  0,041  Antiparasitic
0,330  0,070  Immunostimulant
0,292  0,034  Antihelmintic
0,379  0,121  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,273  0,016  Anesthetic local
0,273  0,016  Succinate dehydrogenase inhibitor
0,275  0,019  Nitric-oxide synthase stimulant
0,265  0,011  Ferrochelatase inhibitor
0,285  0,033  UGT1A4 substrate
0,293  0,046  DNA synthesis inhibitor
0,253  0,007  Triose-phosphate isomerase inhibitor
0,297  0,051  Superoxide dismutase inhibitor
0,315  0,071  12-Lipoxygenase inhibitor
0,296  0,053  Cytostatic
0,247  0,006  Arachidonic acid antagonist
0,305  0,066  CYP1A2 substrate
0,342  0,104  15-Lipoxygenase inhibitor
0,253  0,015  SULT1A3 substrate
0,246  0,008  Antirickettsial
0,277  0,040  Abortion inducer
0,254  0,019  Toxic, respiratory center
0,237  0,003  Elastase 1 inhibitor
0,238  0,005  Alcohol oxidase inhibitor
0,291  0,059  Amyotrophic lateral sclerosis treatment
0,273  0,043  Peroxidase inhibitor
0,233  0,004  Ornithine decarboxylase inhibitor
0,236  0,010  Calcium antagonist
0,245  0,020  Cocaine dependence treatment
0,290  0,065  Insulysin inhibitor
0,229  0,009  Coagulant
0,249  0,032  Antihelmintic (Nematodes)
0,261  0,045  Sedative
0,224  0,009  Gastric antisecretory
0,234  0,018  UGT2B10 substrate
0,243  0,028  Protein kinase stimulant
0,219  0,004  Acetylcholine release stimulant
0,317  0,104  Calpain 2 inhibitor
0,236  0,026  Monophenol monooxygenase inhibitor
0,290  0,080  NOS3 expression inhibitor
0,232  0,023  VEGF expression inhibitor
0,248  0,044  Growth hormone agonist
0,241  0,037  Lipocortins synthesis antagonist
0,242  0,040  Antimutagenic
0,236  0,035  UGT1A3 substrate
0,216  0,015  SULT1A1 substrate
0,213  0,012  Antineoplastic, alkylator
0,208  0,008  Sphingosine 1-phosphate receptor 4 antagonist
0,244  0,045  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,204  0,005  Carbonic anhydrase VB inhibitor
0,210  0,013  Antispirochetal
0,227  0,030  5 Hydroxytryptamine 3E antagonist
0,217  0,021  5-Lipoxygenase inhibitor
0,247  0,051  RNA-directed DNA polymerase inhibitor
0,261  0,066  Acute neurologic disorders treatment
0,204  0,012  Mucolytic
0,208  0,017  Bronchodilator
0,203  0,012  Adenylate cyclase stimulant
0,222  0,033  Lipid peroxidase inhibitor
0,212  0,024  Cholesterol synthesis inhibitor
0,208  0,020  Toll-Like receptor 2 antagonist
0,211  0,024  GABA C receptor rho-2 antagonist
0,198  0,012  Sphingosine 1-phosphate receptor 5 antagonist
0,201  0,015  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,248  0,062  Cytotoxic
0,228  0,044  Sepsis treatment
0,204  0,020  GABA C receptor agonist
0,248  0,066  Calpain inhibitor
0,185  0,005  Ca2+-transporting ATPase inhibitor
0,189  0,008  Carbonic anhydrase V inhibitor
0,195  0,015  Mediator release inhibitor
0,252  0,073  Myocardial infarction treatment
0,234  0,056  Nitric oxide antagonist
0,236  0,058  Platelet aggregation inhibitor
0,214  0,036  Acetylcholine M1 receptor antagonist
0,193  0,017  Catalase inhibitor
0,197  0,022  Aminopeptidase B inhibitor
0,204  0,029  Calcium channel blocker
0,300  0,125  CYP2C19 inhibitor
0,232  0,058  Antiviral (West Nile virus)
0,187  0,014  TRPA1 agonist
0,213  0,040  Diuretic
0,207  0,036  UGT2B9 substrate
0,206  0,039  Cyclooxygenase inhibitor
0,189  0,023  Expectorant
0,172  0,007  Carbonic anhydrase VA inhibitor
0,266  0,105  AR expression inhibitor
0,220  0,060  UGT1A1 substrate
0,201  0,042  UGT2B15 substrate
0,207  0,049  Antianorexic
0,180  0,022  Menstruation disorders treatment
0,172  0,014  Actinic keratosis treatment
0,182  0,026  Antiviral (Poxvirus)
0,191  0,035  Antifungal enhancer
0,243  0,087  Cardiotonic
0,194  0,038  Neurotensin receptor agonist
0,186  0,031  Alkylator
0,193  0,039  Skin whitener
0,208  0,055  Diabetic retinopathy treatment
0,162  0,009  Antiviral (Rhinovirus)
0,197  0,045  Amylase inhibitor
0,158  0,007  Antidote, heavy metal
0,171  0,020  Adenylate kinase inhibitor
0,154  0,003  Exportin-1 inhibitor
0,194  0,043  Melanin inhibitor
0,181  0,030  Cell adhesion inhibitor
0,210  0,059  Hepatoprotectant
0,180  0,031  Glutathione S-transferase substrate
0,191  0,043  Thiol protease inhibitor
0,167  0,019  Chronic obstructive bronchitis treatment
0,191  0,044  Interferon gamma antagonist
0,173  0,028  Microtubule formation inhibitor
0,149  0,004  Estrogen-related receptor beta agonist
0,193  0,049  Muscular dystrophy treatment
0,155  0,011  Phenylalanine 4-hydroxylase inhibitor
0,216  0,072  Anticonvulsant
0,245  0,102  Antiepileptic
0,163  0,021  HIV-1 integrase (Overall Integration) inhibitor
0,163  0,020  Caspase 3 inhibitor
0,174  0,032  Acetylcholine muscarinic antagonist
0,218  0,077  Antiviral (HIV)
0,166  0,025  Vanilloid 1 agonist
0,153  0,012  Glutamate decarboxylase inhibitor
0,172  0,032  Antihemorrhagic
0,173  0,033  Farnesoid X receptor antagonist
0,150  0,011  Restless leg syndrome treatment
0,180  0,041  Allergic rhinitis treatment
0,172  0,034  Interleukin 4 antagonist
0,155  0,017  Antifungal (Pneumocystis)
0,169  0,030  Antineoplastic antimetabolite
0,187  0,049  ATPase inhibitor
0,182  0,044  Genotoxic
0,172  0,035  Proteasome inhibitor
0,243  0,107  Hypoxia-inducible factor 1 alpha inhibitor
0,276  0,140  Atherosclerosis treatment
0,171  0,036  Antieczematic
0,160  0,025  UGT2B1 substrate
0,154  0,020  Porphobilinogen synthase inhibitor
0,168  0,034  Cystathionine beta-synthase inhibitor
0,142  0,008  Glycine receptor agonist
0,174  0,040  Cholinergic antagonist
0,168  0,034  Antibacterial (Helicobacter pylori)
0,218  0,085  Antihypotensive
0,151  0,018  Phosphofructokinase-1 inhibitor
0,184  0,053  Neuropathy treatment
0,150  0,019  Electrolyte absorption antagonist
0,151  0,020  DOPA decarboxylase inhibitor
0,166  0,035  Adenylate cyclase inhibitor
0,188  0,058  Antipruritic
0,162  0,033  Beta amyloid protein antagonist
0,181  0,052  Uterine stimulant
0,156  0,026  Antihelmintic (Fasciola)
0,147  0,018  Interleukin 1 beta converting enzyme inhibitor
0,140  0,012  Interferon agonist
0,157  0,029  Contraceptive female
0,149  0,022  Carcinogenic, group 2A
0,216  0,089  Antiamyloidogenic
0,197  0,070  CYP2B6 inhibitor
0,161  0,034  Growth stimulant
0,169  0,042  Cyclooxygenase 2 inhibitor
0,184  0,057  Phospholipase C inhibitor
0,149  0,023  Prolactin inhibitor
0,137  0,012  Calcium channel L-type blocker
0,131  0,006  Carbonic anhydrase XIV inhibitor
0,143  0,018  Paget's disease treatment
0,157  0,033  Sphingosine 1-phosphate receptor 2 antagonist
0,133  0,009  Granulocyte macrophage colony stimulating factor agonist
0,166  0,042  Acetylcholine antagonist
0,140  0,016  Interleukin 12 antagonist
0,143  0,021  Histidine decarboxylase inhibitor
0,154  0,032  Shock treatment
0,129  0,008  Protease 3C (Human rhinovirus) inhibitor
0,150  0,030  GABA C receptor antagonist
0,132  0,013  Sphingosine 1-phosphate receptor 4 agonist
0,186  0,067  Amyloid beta precursor protein antagonist
0,148  0,029  Sulfotransferase substrate
0,134  0,016  Aminopeptidase I inhibitor
0,145  0,026  Creatine kinase inhibitor
0,248  0,130  Sodium/bile acid cotransporter inhibitor
0,140  0,024  Anabolic
0,177  0,063  Phobic disorders treatment
0,199  0,085  Interleukin antagonist
0,140  0,026  GABA C receptor rho-1 antagonist
0,190  0,077  UDP-glucuronosyltransferase substrate
0,163  0,050  Cyclooxygenase 1 inhibitor
0,122  0,009  Antiviral (Herpesvirus 3, Human)
0,129  0,017  Antiprotozoal activity enhancer
0,125  0,013  Biliverdin reductase inhibitor
0,162  0,051  Bone formation stimulant
0,130  0,020  Glutamate dehydrogenase inhibitor
0,134  0,024  UGT2B11 substrate
0,155  0,046  Retinoprotector
0,153  0,044  Cathepsin H inhibitor
0,119  0,011  Acetylcholine M5 receptor agonist
0,127  0,019  Keratolytic
0,128  0,021  Cell adhesion molecule inhibitor
0,129  0,022  Macrophage migration inhibitory factor inhibitor
0,115  0,008  Interferon inducer
0,139  0,033  Transcription factor STAT6 inhibitor
0,113  0,008  Antiviral (Parainfluenza)
0,117  0,013  Antiemphysemic
0,163  0,059  Raynaud's phenomenon treatment
0,130  0,025  Thioredoxin inhibitor
0,127  0,023  Antidote, mercury
0,134  0,032  Sphingomyelinase inhibitor
0,114  0,012  Beta adrenoreceptor antagonist
0,122  0,020  Peroxisome proliferator-activated receptor gamma agonist
0,159  0,057  Antiacne
0,121  0,019  Bile acid receptor antagonist
0,236  0,135  Interleukin 2 agonist
0,104  0,003  Sodium-dependent vitamin C transporter 2 inhibitor
0,110  0,009  Antidote, organophosphates
0,188  0,087  DNA methylase inhibitor
0,136  0,037  Carbonic anhydrase XV inhibitor
0,105  0,006  Nitric oxide donor
0,125  0,026  NADH dehydrogenase inhibitor
0,103  0,005  Lysophosphatidic acid 3 receptor antagonist
0,157  0,059  CNS active muscle relaxant
0,111  0,013  Anticholelithogenic
0,101  0,004  GABA uptake inhibitor
0,113  0,017  Leukotriene antagonist
0,110  0,014  Acyl-CoA dehydrogenase inhibitor
0,111  0,017  Narcotic antagonist
0,118  0,024  Glutathione S-transferase inhibitor
0,128  0,034  Antineoplastic alkaloid
0,168  0,076  3C-like protease (Human coronavirus) inhibitor
0,222  0,130  Antifungal
0,184  0,092  Antiviral (Ebola)
0,121  0,030  ABCA1 expression enhancer
0,174  0,084  DNA methyltransferase I inhibitor
0,159  0,070  Protein-tyrosine phosphatase inhibitor
0,258  0,169  Antibacterial
0,152  0,064  Cell wall synthesis inhibitor
0,189  0,100  Angiogenesis stimulant
0,097  0,010  SULT2A1 substrate
0,098  0,011  Glutamate (mGluR6) antagonist
0,132  0,046  Antiviral (Influenza B)
0,117  0,031  Acetylcholine nicotinic antagonist
0,126  0,040  Carbonic anhydrase III inhibitor
0,105  0,019  Carbamoyl phosphate synthetase inhibitor
0,137  0,052  Protein-tyrosine phosphatase 1B inhibitor
0,094  0,009  Aconitate hydratase inhibitor
0,100  0,015  Peroxisome proliferator-activated receptor gamma antagonist
0,107  0,023  Acetylcholine M4 receptor antagonist
0,117  0,033  Lanosterol 14 alpha demethylase inhibitor
0,209  0,125  Antidiabetic (type 2)
0,090  0,007  Squalene synthetase inhibitor
0,088  0,005  Adenylate cyclase 1 inhibitor
0,093  0,012  Leukotriene B4 antagonist
0,091  0,010  Potassium channel Kv1.3 blocker
0,113  0,032  NAD(P)H dehydrogenase (quinone) inhibitor
0,111  0,030  Adrenaline agonist
0,152  0,073  CF transmembrane conductance regulator agonist
0,096  0,018  Endocannabinoid uptake inhibitor
0,152  0,074  Aldose reductase substrate
0,086  0,008  Anesthetic inhalation
0,115  0,038  Alcohol dehydrogenase inhibitor
0,143  0,066  Pancreatic disorders treatment
0,199  0,122  Antiprotozoal (Trypanosoma)
0,102  0,026  Carbonic anhydrase inhibitor
0,081  0,006  Cholesterol esterase inhibitor
0,150  0,075  Cytidine deaminase inhibitor
0,125  0,051  Calcium channel (voltage-sensitive) blocker
0,088  0,014  Beta 1 adrenoreceptor antagonist
0,081  0,007  Retinoid X alpha receptor agonist
0,099  0,025  Amidase inhibitor
0,142  0,069  Heat shock protein 70 antagonist
0,094  0,021  Argininosuccinate synthase inhibitor
0,092  0,020  Maillard reaction inhibitor
0,127  0,054  Antiprotozoal (Babesia)
0,082  0,010  Prolyl endopeptidase inhibitor
0,087  0,015  Peroxisome proliferator-activated receptor alpha agonist
0,149  0,077  Pulmonary hypertension treatment
0,150  0,078  Antiviral (Herpes)
0,106  0,035  Glutamate release inhibitor
0,122  0,051  Rhinitis treatment
0,079  0,008  Retinoid X receptor agonist
0,078  0,008  Pregnane X receptor antagonist
0,144  0,074  Corneal wound healing stimulator
0,085  0,015  Dopamine transporter inhibitor
0,104  0,035  Tocolytic
0,129  0,060  Antiviral (Papilloma)
0,076  0,007  Prostaglandin agonist
0,153  0,084  Prostate disorders treatment
0,090  0,021  Dopamine uptake inhibitor
0,090  0,022  NMDA receptor glycine site agonist
0,102  0,035  Inducible nitric-oxide synthase inhibitor
0,087  0,021  Uterine relaxant
0,080  0,014  Postcoital contraceptive
0,215  0,149  Antineoplastic (brain cancer)
0,099  0,033  Na+ K+ transporting ATPase inhibitor
0,080  0,014  Lipocortins synthesis agonist
0,079  0,013  Leukocyte elastase inhibitor
0,096  0,031  NAT1 substrate
0,076  0,010  Glucose-6-phosphate isomerase inhibitor
0,164  0,098  Amyloid beta aggregation inhibitor
0,100  0,035  Histamine H2 receptor antagonist
0,077  0,012  Acetyl-CoA transferase 2 inhibitor
0,098  0,034  Cathepsin G inhibitor
0,164  0,101  Antiarrhythmic
0,178  0,115  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,123  0,060  Alcohol dehydrogenase substrate
0,089  0,027  GABA B receptor agonist
0,177  0,115  Antiprotozoal (Leishmania)
0,073  0,011  Fructose-1,6-bisphosphatase inhibitor
0,078  0,017  Elastase inhibitor
0,096  0,035  Nicotinic alpha4beta2 receptor antagonist
0,079  0,018  Sphingosine 1-phosphate receptor 3 antagonist
0,074  0,014  Beta 2 adrenoreceptor antagonist
0,072  0,012  Leukotriene C antagonist
0,092  0,033  GABA aminotransferase inhibitor
0,083  0,024  Carbonic anhydrase I inhibitor
0,099  0,040  Transcription factor NF kappa B stimulant
0,140  0,082  Antiviral (Influenza A)
0,143  0,085  Restenosis treatment
0,210  0,152  Immunomodulator
0,073  0,015  Beta 2 adrenoreceptor agonist
0,067  0,009  Nicotinic acid receptor agonist
0,061  0,003  Elastase 3B inhibitor
0,061  0,003  Elastase 3A inhibitor
0,061  0,003  Elastase 2B inhibitor
0,117  0,059  Aldehyde dehydrogenase substrate
0,083  0,025  Prostaglandin EP2 antagonist
0,143  0,086  Movement disorders treatment
0,060  0,004  Prostaglandin F2 alpha agonist
0,078  0,021  Thromboxane antagonist
0,066  0,010  Dopamine D5 agonist
0,071  0,015  Carbonic anhydrase VII inhibitor
0,077  0,022  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,076  0,021  NMDA 2A receptor antagonist
0,127  0,073  Antihelmintic (Trematoda)
0,083  0,029  HIV-1 integrase (Strand Transfer) inhibitor
0,142  0,088  Thrombolytic
0,068  0,015  Adenosine deaminase inhibitor
0,105  0,052  Nitric-oxide synthase inhibitor
0,079  0,026  Purinergic P2X1 antagonist
0,102  0,049  Phosphodiesterase 6D inhibitor
0,102  0,049  Antifungal (Candida)
0,097  0,045  Interleukin 5 antagonist
0,058  0,006  Free fatty acid receptor 1 antagonist
0,091  0,040  Caspase 7 inhibitor
0,080  0,029  NMDA receptor agonist
0,067  0,016  Carbonic anhydrase IV inhibitor
0,071  0,020  Thromboxane A2 antagonist
0,055  0,005  Methionyl aminopeptidase 1 inhibitor
0,111  0,061  Choleretic
0,076  0,026  Antimycoplasmal
0,077  0,026  Carbonic anhydrase II inhibitor
0,076  0,026  Beta 3 adrenoreceptor antagonist
0,069  0,019  Thromboxane synthase inhibitor
0,079  0,029  Glutamate (mGluR7) antagonist
0,107  0,059  Toll-Like receptor 4 antagonist
0,096  0,049  NMDA receptor antagonist
0,067  0,020  Nicotinic alpha3beta2 receptor antagonist
0,125  0,079  Antiprotozoal (Trichomonas)
0,089  0,043  Thioredoxin reductase inhibitor
0,200  0,154  Bone diseases treatment
0,056  0,010  Angiotensin AT1 receptor antagonist
0,063  0,019  Immunoglobulin Fc receptor antagonist
0,203  0,159  Thyroid hormone antagonist
0,221  0,178  Toll-Like receptor agonist
0,073  0,030  Narcolepsy treatment
0,088  0,045  Glycine receptor antagonist
0,072  0,030  Acetylcholine M3 receptor antagonist
0,101  0,059  Glutamate (mGluR7) agonist
0,050  0,008  Peroxisome proliferator-activated receptor alpha antagonist
0,069  0,027  Potassium channel intermediate-conductance Ca-activated blocker
0,100  0,058  Tourette's syndrome treatment
0,046  0,004  Nicotinic acid receptor 2 antagonist
0,053  0,012  Fumarate hydratase inhibitor
0,129  0,087  Mannose-6-phosphate isomerase inhibitor
0,057  0,016  Benzodiazepine antagonist
0,082  0,041  Lipase inhibitor
0,082  0,042  Sphingosine 1-phosphate receptor antagonist
0,194  0,155  CYP2D6 inhibitor
0,043  0,005  Lysophosphatidic acid receptor 1 agonist
0,077  0,039  Leukotriene synthesis inhibitor
0,055  0,017  Glutamate (mGluR4) antagonist
0,074  0,037  HIV-1 integrase (3'-Processing) inhibitor
0,049  0,011  Leukotriene C4 antagonist
0,044  0,007  Prostaglandin EP2 agonist
0,062  0,025  Alpha-mannosidase inhibitor
0,078  0,041  S-adenosyl-L-methionine decarboxylase inhibitor
0,203  0,168  CYP3A4 inhibitor
0,044  0,010  Angiotensin II receptor antagonist
0,041  0,006  Elastase 2A inhibitor
0,041  0,006  Elastase 2 inhibitor
0,048  0,014  Prostacyclin antagonist
0,053  0,019  Antiviral (Enterovirus)
0,053  0,019  Leukotriene A4 hydrolase inhibitor
0,051  0,017  Dihydrofolate reductase inhibitor
0,102  0,068  HDL-cholesterol increasing
0,050  0,017  Beta adrenoreceptor agonist
0,143  0,110  Tumour necrosis factor antagonist
0,067  0,034  Carbonic anhydrase IX inhibitor
0,113  0,080  Antiprotozoal (Amoeba)
0,048  0,016  Kainate receptor agonist
0,055  0,022  Dopamine beta hydroxylase inhibitor
0,070  0,038  MDM2 inhibitor
0,059  0,026  Antimetabolite
0,064  0,032  Human rhinovirus A protease inhibitor
0,062  0,030  Ornithine carbamoyltransferase inhibitor
0,129  0,098  Insulin secretagoues
0,086  0,055  Vanilloid agonist
0,088  0,057  Histamine N-methyltransferase inhibitor
0,046  0,015  Cholesterol absorption inhibitor
0,215  0,185  Antiasthmatic
0,074  0,044  Prostaglandin-E synthase inhibitor
0,079  0,049  CYP2A6 inhibitor
0,042  0,012  Tryptophan 5 hydroxylase inhibitor
0,115  0,086  Gastritis treatment
0,063  0,034  Sphingosine kinase inhibitor
0,087  0,058  Antileprosy
0,050  0,021  Glutamate (mGluR group III) antagonist
0,052  0,024  Cytokine production stimulant
0,066  0,038  Calcium channel P-type blocker
0,047  0,019  Dihydropteroate synthase inhibitor
0,108  0,080  Autism spectrum disorders treatment
0,037  0,009  Sodium/glucose cotransporter 2 inhibitor
0,106  0,078  Antitussive
0,032  0,005  Isoleucine-tRNA ligase inhibitor
0,213  0,186  Toll-Like receptor 7 agonist
0,070  0,043  Gaucher disease treatment
0,051  0,024  Sphingosine 1-phosphate receptor agonist
0,190  0,163  Thyroid hormone beta antagonist
0,043  0,016  Vanilloid 3 antagonist
0,059  0,033  Carbonic anhydrase XII inhibitor
0,067  0,041  Hyperparathyroidism treatment
0,043  0,017  Glutamate (mGluR8) agonist
0,045  0,019  Arginase inhibitor
0,039  0,013  Calcium-independent phospholipase A2 inhibitor
0,052  0,026  Oleamide hydrolase inhibitor
0,032  0,006  Fructose-1,6-bisphosphatase 1 inhibitor
0,039  0,013  Lysophosphatidic acid 2 receptor antagonist
0,038  0,013  Uridine phosphorylase inhibitor
0,144  0,119  Septic shock treatment
0,093  0,067  Xanthine oxidase inhibitor
0,033  0,007  Vanilloid 2 agonist
0,063  0,038  Acetylcholine M5 receptor antagonist
0,034  0,009  Prostaglandin E2 agonist
0,087  0,062  ATPase (Vacuolar H+) inhibitor
0,072  0,047  Dysmenorrhea treatment
0,113  0,088  DNA repair enzyme inhibitor
0,050  0,025  Mannosidase inhibitor
0,074  0,050  Potassium channel (Tandem pore domain) blocker
0,039  0,015  Acetylcholine M4 receptor agonist
0,043  0,019  Bombesin 1 receptor antagonist
0,045  0,022  Heme oxygenase inhibitor
0,083  0,060  Myeloperoxidase inhibitor
0,102  0,079  Interleukin 1b antagonist
0,164  0,141  Tumour necrosis factor alpha release inhibitor
0,042  0,019  Glutamate (mGluR3) antagonist
0,032  0,010  Sodium/glucose cotransporter inhibitor
0,040  0,017  1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor
0,081  0,059  Acetylcholine M3 receptor agonist
0,128  0,106  Pregnane X receptor agonist
0,039  0,018  Peroxisome proliferator-activated receptor delta agonist
0,105  0,085  MAO inhibitor
0,095  0,075  Falcipain 3 inhibitor
0,046  0,026  Histamine H2 receptor agonist
0,024  0,004  Lysophosphatidic acid receptor 3 agonist
0,043  0,023  NMDA receptor subunit 3A antagonist
0,027  0,008  GABA transporter inhibitor
0,041  0,022  Retinoid X receptor antagonist
0,035  0,016  Glutamate (mGluR3) agonist
0,024  0,006  Vesicular glutamate transport inhibitor
0,044  0,026  Sphingosine 1-phosphate receptor 1 agonist
0,167  0,148  Chronic obstructive pulmonary disease treatment
0,170  0,152  Antiosteoporotic
0,043  0,025  3-Hydroxyanthranilate 3,4-dioxygenase inhibitor
0,024  0,006  Carbonic anhydrase VIII inhibitor
0,024  0,006  Carbonic anhydrase X inhibitor
0,029  0,011  Sodium/glucose cotransporter 1 inhibitor
0,073  0,056  SULT1A2 substrate
0,061  0,044  Acetylcholine M2 receptor antagonist
0,104  0,087  Interleukin 8 antagonist
0,042  0,024  Membrane dipeptidase inhibitor
0,073  0,056  Vanilloid 4 agonist
0,059  0,042  Aromatase inhibitor
0,036  0,020  Retinoid X alpha receptor antagonist
0,086  0,070  MAO B inhibitor
0,023  0,007  Estrogen-related receptor gamma agonist
0,053  0,037  Heparanase inhibitor
0,055  0,040  Sphingosine 1-phosphate receptor 1 antagonist
0,028  0,013  Acid ceramidase inhibitor
0,031  0,017  Thiazolidinedione
0,095  0,081  Antiinfertility, female
0,022  0,008  Prostacyclin agonist
0,043  0,029  Guanylate cyclase inhibitor
0,122  0,108  Urolithiasis treatment
0,034  0,021  Carboxypeptidase B inhibitor
0,057  0,044  Carbonic anhydrase stimulant
0,131  0,117  Cystic fibrosis treatment
0,029  0,016  Prostaglandin EP4 antagonist
0,028  0,015  Thyroid hormone agonist
0,029  0,015  Glucosylceramidase stimulant
0,023  0,010  Retinoid X beta receptor antagonist
0,113  0,100  Interleukin 1 antagonist
0,020  0,009  Prostaglandin EP4 agonist
0,056  0,044  Botulinum neurotoxin type A inhibitor
0,018  0,006  GABA transporter 1 inhibitor
0,044  0,032  Purinergic P2Y antagonist
0,066  0,055  HIV-1 integrase inhibitor
0,122  0,110  Hemostatic
0,048  0,037  Topoisomerase II beta inhibitor
0,023  0,012  Corticosteroid-like
0,068  0,058  Antibiotic
0,033  0,023  Sirtuin 2 inhibitor
0,033  0,024  Melatonin receptor 1A agonist
0,028  0,019  LFA antagonist
0,052  0,043  Glucosylceramidase inhibitor
0,022  0,013  Lysophosphatidic acid 1 receptor antagonist
0,044  0,035  Microtubule stabilization
0,082  0,073  Potassium channel (Ca-activated) activator
0,027  0,018  Sigma 1 receptor antagonist
0,056  0,047  Androgen agonist
0,176  0,168  Neuropeptide Y2 antagonist
0,026  0,017  Prostaglandin H2 antagonist
0,020  0,012  Antibiotic Anthracycline-like
0,016  0,008  Angiotensin AT1B receptor antagonist
0,124  0,116  Antinephritic
0,073  0,065  Chymotrypsin inhibitor
0,038  0,031  Toll-Like receptor 2 agonist
0,047  0,040  Squalene epoxidase inhibitor
0,026  0,019  Integrin alpha2beta1 antagonist
0,018  0,012  Methylmalonyl-CoA mutase inhibitor
0,049  0,043  Acetyl-CoA transferase inhibitor
0,039  0,033  Sphingosine kinase 1 inhibitor
0,012  0,006  Angiotensin AT2 receptor agonist
0,040  0,034  NMDA receptor subunit 3B antagonist
0,043  0,038  Purinergic P2X4 antagonist
0,035  0,029  Integrin alpha2 antagonist
0,027  0,022  Estrogen-related receptor gamma antagonist
0,145  0,140  Aryl hydrocarbon receptor agonist
0,158  0,153  Heart failure treatment
0,021  0,016  Glutamate (mGluR1a) agonist
0,051  0,046  Angiotensin-converting enzyme inhibitor
0,155  0,150  Antineoplastic (renal cancer)
0,248  0,244  Antineoplastic (solid tumors)
0,087  0,082  NAT2 substrate
0,051  0,047  Epithelial sodium channel blocker
0,038  0,034  Thymidine kinase inhibitor
0,033  0,030  5-Alpha-reductase inhibitor
0,011  0,007  Thromboxane agonist
0,046  0,043  Aldose reductase inhibitor
0,045  0,042  Bombesin 2 receptor antagonist
0,038  0,035  VCAM-1 antagonist
0,037  0,035  VCAM antagonist
0,027  0,024  DNA polymerase III inhibitor
0,083  0,081  Anticataract
0,020  0,018  Neuraminidase (Influenza B) inhibitor
0,016  0,013  Vitamin D receptor agonist
0,049  0,048  Matrix metalloproteinase (membrane-type) inhibitor
0,066  0,065  CDC25A inhibitor
0,017  0,016  Vesicular acetylcholine transporter inhibitor
0,048  0,047  Vanilloid 2 antagonist
0,039  0,038  GABA B receptor antagonist
0,012  0,011  Human herpes virus 5 capsid protein P40 inhibitor
0,047  0,046  Autotaxin inhibitor
0,055  0,054  Ryanodine receptor antagonist
0,013  0,012  DNA polymerase III polC-type inhibitor
0,135  0,134  LDLR expression enhancer
0,030  0,030  Kainate receptor 2 antagonist
0,035  0,035  Vesicle monoamine transporter inhibitor
0,163  0,163  Age-related macular degeneration treatment
0,020  0,020  GRP78 expression inhibitor

